Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
12081
Table_3_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien...
Published 2022“…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”
-
12082
Table_2_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien...
Published 2022“…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”
-
12083
Supplementary file 1_The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotempor...
Published 2025“…</p>Results<p>In 2021, the global age-standardized prevalence rate (ASPR) of PCOS was 867.7 per 100,000 [95% UI: 618.7–1,195.3], representing a significant increase of 0.75 compared with 1990 [95% CI: 0.71–0.78]. …”
-
12084
Stimulus protocols.
Published 2013“…Self-sustained activity was evident in the right wrist extensors with both stimulus patterns, but not in the right thenar muscles. A: 25 Hz for 2 s then 100 Hz for 2 s then 25 Hz for 3 s, C: ramp stimulus, increasing from 1 Hz to 100 Hz over 5 s and then decreasing to 1 Hz over 5 s.…”
-
12085
Biomechanical findings in horses showing asymmetrical vertical excursions of the withers at walk
Published 2018“…The forelimb that was retracted when T6min was lowest showed greater retraction at toe-off (1 mm increase predicted 0.17 mm T6minDiff increase) and shorter stance duration (1 ms decrease predicted 0.3 mm T6minDiff increase). The hind limb that was in midstance when T6min was lowest showed a greater range of motion during the stance phase (1 mm increase in protraction or retraction predicted 0.2 mm T6minDiff increase). …”
-
12086
Involvement of Abscisic Acid in PSII Photodamage and D1 Protein Turnover for Light-Induced Premature Senescence of Rice Flag Leaves
Published 2016“…The <i>psf</i> showed evidently decreased D1 protein amount in the senescent leaves. …”
-
12087
Crystal size distributions.
Published 2012“…(c) 3D view of pumice chip (sample AB-6203F), showing euhedral quartz and feldspar grains (green), magnetite (blue), and pyroxene±biotite (white); notice the overall trend of decreasing numbers of crystals with increasing size; sample is approximately cylindrical, field of view ∼9 mm (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037492#pone.0037492.s001" target="_blank">Movie S1</a> for animated version). …”
-
12088
DataSheet1_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…Furthermore, we found that use of the BiOM with 10% and 20% greater than recommended power increased AL<sub>trail</sub> W<sub>pos</sub> and decreased UL<sub>lead</sub> W<sub>neg</sub> magnitude at 0.75–1.00 m/s. …”
-
12089
DataSheet4_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…Furthermore, we found that use of the BiOM with 10% and 20% greater than recommended power increased AL<sub>trail</sub> W<sub>pos</sub> and decreased UL<sub>lead</sub> W<sub>neg</sub> magnitude at 0.75–1.00 m/s. …”
-
12090
DataSheet3_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du...
Published 2024“…Furthermore, we found that use of the BiOM with 10% and 20% greater than recommended power increased AL<sub>trail</sub> W<sub>pos</sub> and decreased UL<sub>lead</sub> W<sub>neg</sub> magnitude at 0.75–1.00 m/s. …”
-
12091
2D Conductive Iron-Quinoid Magnets Ordering up to <i>T</i><sub>c</sub> = 105 K via Heterogenous Redox Chemistry
Published 2017“…The oxidized compound, (Me<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>[Fe<sub>2</sub>L<sub>3</sub>]·2H<sub>2</sub>O·6DMF (LH<sub>2</sub> = 2,5-dichloro-3,6-dihydroxo-1,4-benzoquinone) was previously shown to magnetically order below 80 K in its solvated form, with the ordering temperature decreasing to 26 K upon desolvation. Here, we demonstrate this compound to exhibit electrical conductivity values up to σ = 1.4(7) × 10<sup>–2</sup> S/cm (<i>E</i><sub>a</sub> = 0.26(1) cm<sup>–1</sup>) and 1.0(3) × 10<sup>–3</sup> S/cm (<i>E</i><sub>a</sub> = 0.19(1) cm<sup>–1</sup>) in its solvated and desolvated forms, respectively. …”
-
12092
Data Sheet 1_Global, regional, and national burden of 34 cancer groups across 204 countries and territories, 1990–2021, and projections to 2050: a systematic analysis of the Global...
Published 2025“…</p>Results<p>In 2021, there were 23.57 million new cases and 9.83 million deaths, with a global age-standardized incidence rate (ASIR) of 275.2 per 100,000 and age-standardized mortality rate (ASMR) of 115.8 per 100,000. …”
-
12093
IFNγ-induced inhibition of <i>C. trachomatis</i> growth in WT MEFs.
Published 2009“…The yield of <i>C. trachomatis</i> (B), but not <i>C. muridarum</i> (D), infectious progeny decreased considerably upon IFNγ stimulation, Infectivity percentage calculated as follows: IFU/ml estimated for each treated monolayer / IFU/ml of control cells ×100. …”
-
12094
Forecast variation of ecoclimatic suitability between historical climate (current EI) and 2070 projected climate (future EI) from A2 climate scenarios using CSIRO-MK3.0 climate mod...
Published 2014“…<p>a) qualitative variation highlighted the expansion (current EI = 0, future EI>0) and the contraction (current EI>0, future EI = 0) of suitable areas for 2070 projection. b) quantitative variation illustrated climatic suitability increases or decreases. …”
-
12095
Histological (a, b, c) and immunohistological (d–i) stainings (CD3: d–f; HLA class I expression: g–i) of the EMBs at the initial presentation, at 6 and 12 months follow-up.
Published 2013“…The initially increased CD3<sup>+</sup> T-cells and HLA class I expression decreased at the follow-up EMBs. Original magnification a–f: 200×fold. …”
-
12096
Inhibition of cilia disassembly protects RGCs and suppresses cell cycling after ONT.
Published 2019“…Scale bar = 100 μm. (B) Quantification of RGCs after intravitreal injection of the TBA (n = 4 retinas) or AurA inhibitor I (n = 5 retinas), demonstrating significantly increased RGC survival at 14 days post-ONT compared to DMSO control treatment (**p<0.01). …”
-
12097
Schematic model of darkness-responsive proteins in chloroplasts of <i>Arabidopsis</i> leaves.
Published 2016“…The solid line means one step. The dot line means multiple steps. A, Photosynthesis and chlororespiration; B, Chlorophyll synthesis; C, Calvin cycle; D, Transcription; E, Protein synthesis, folding and degradation; F, Fransportation; G, JA signaling; Abbreviations: ADPGlu, ADPglucose; AOC4, allene oxide cyclase 4; AOS, allene oxide synthase; CCL, CCR-like; Chlide, chlorophyllide; CP26, chlorophyll a-b binding protein; CPOX, Coproporphyrinogen-III oxidase 1; CRD1, Magnesium-protoporphyrin IX monomethyl ester [oxidative] cyclase; CYP20-3, cyclophilin 20–3; Cytb6f, cytochrome b6/f; DEG8, Protease DEG 8; DHAP, dihydroxyacetone phosphate; 12,13-EOT, 12,13-epoxy-octadecatrienoic acid; F6P, fructose-6-phosphate; F1,6BP, fructose-1,6-bisphosphate; FBA, fructose-bisphosphate aldolase; FBA3, probable fructose-bisphosphate aldolase 3; Fd, sulfite reductase [ferredoxin]; FKBP16-1, peptidyl-prolylcis-trans isomerase FKBP16-1; FKBP16-4, peptidyl-prolylcis-trans isomerase FKBP16-4; FKBP19, peptidyl-prolylcis-trans isomerase FKBP19; FNR, Fd:NADP<sup>+</sup> oxidoreductase; FtsH, FtsH extracellular protease family protein; FUG1 Translation initiation factor IF-2; Glu6P, Glucose-6-phosphate; GSH, glutathione; KEA3, K+ efflux antiporter 3; LHCA2, Photosystem I light harvesting complex gene2 protein; LHCB1, light-harvesting chlorophyll protein complex II subunit B1; Mg-Proto, Mg-protoporphyrin; OPDA, (+)-12-oxophytodienoic acid; Pchlide, protochlorophyllide; PDE322, chloroplast RNA-binding protein 33; PEP, phosphoenolpyruvic acid; PEPCK, phosphoenolpyruvate carboxylase family protein; 1,3PGA, 1,3-bisphospoglycerate; 3PGA, 3-phosphoglycerate; PGRL1, PGR5-like protein 1; PHT2;1, inorganic phosphate transporter 2–1; PKP1, Plastidial pyruvate kinase 1; POR, Protochlorophyllide reductase like protein; PQ, plastoquinone pool; Proto-IX, protoporphyrin-IX; PSAA, photosystem I P700 chlorophyll a apoprotein A1; PSB33, Rieske (2Fe-2S) domain-containing protein; PsbP, photosystem II subunit P; PsbQ, photosystem II subunit Q; PSRP2, RNA-binding (RRM/RBD/RNP motifs) family protein; pTAC5, plastid transcriptionally active 5; PTOX, plastid terminal oxidase; R5P, ribulose-5-phosphate; RBP31, 31-kDa RNA binding protein; RRF, ribosome-recycling factor; RuBisCO, ribulose bisphosphate carboxylase; RuBP, Ribulose-1,5-bisphosphate; SBPase, sedoheptulose-1,7-bisphosphatase; SCY1, preprotein translocase subunit SCY1; Sd7P, sedoheptulose-7-phosphate; Sd1,7bP, sedoheptulose-1,7-bisphosphate; STN7, serine/threonine-protein kinase STN7; STN8, serine/threonine-protein kinase STN8; TAL, transaldolase-like protein; TGA, transcription factors; Toc64, Outer envelope protein 64; TPI, triosephosphate isomerase; TPT, triose phosphate/phosphate translocator; Triose P, Glyceraldehyde 3-phosphate; TROL, thylakoid rhodanese-like protein; TRX, thioredoxins; Xy5P, xylulose-5-phosphate.…”
-
12098
Data Sheet 4_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for...
Published 2025“…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”
-
12099
Data Sheet 5_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for...
Published 2025“…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”
-
12100
Data Sheet 6_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for...
Published 2025“…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”